Effect of Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Reduced Ejection Fraction
Source · ClinicalTrials.gov: elamipretide
TLDR
ClinicalTrials.gov lists a completed trial evaluating Elamipretide’s effect on left ventricular function in people with stable heart failure with reduced ejection fraction. The study was randomized, double-blinded, and placebo-controlled; the provided excerpt does not include results.
- 01The trial enrolled subjects with stable heart failure with reduced ejection fraction.
- 02The study used a randomized, double-blinded, placebo-controlled, multiple-dose design.
- 03Completion status is reported, but efficacy and safety findings are not provided.
Why it matters Editorial
The listing documents clinical evaluation of Elamipretide in heart failure, but the excerpt does not establish whether it improved heart function.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
ClinicalTrials.gov: elamipretide
ClinicalTrials.gov: elamipretide
ClinicalTrials.gov: elamipretide
ClinicalTrials.gov: elamipretide